Methods for cloning mammals using reprogrammed donor chromatin or donor cells

Abstract

The invention provides methods for cloning mammals that allow the donor chromosomes or donor cells to be reprogrammed prior to insertion into an enucleated oocyte. The invention also features methods of inserting chromosomes or nuclei into recipient cells.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application is a divisional application of and claims priority from U.S. patent application Ser. No. 10 / 032,191, filed Dec. 21, 2001, which claims benefit of the filing date of U.S. Provisional Application No. 60 / 258,151, filed Dec. 22, 2000, hereby incorporated by reference.BACKGROUND OF THE INVENTION [0002] In general, the invention features improved methods for cloning mammals and methods for inserting chromosomes, nuclei, or chromatin masses into recipient cells. [0003] The cloning of mammals allows the production of multiple mammals with an identical DNA content. The donor genetic material used to generate these mammals may be selected or engineered such that the cloned mammals have desirable properties, such as increased resistance to disease. Unfortunately, the efficiency of cloning mammals using donor somatic cells is generally low, resulting in only about 1-2% of nuclear transplant embryos developing to term (Polejaeva et a...

AI Technical Summary

Benefits of technology

[0004] The purpose of the present invention is to provide improved methods for cloning mammals. In particular, these methods involve the condensation of a donor nucleus into a chromatin mass to allow the release of nuclear components such as transcription factors that may promote the transcription of genes that are undesirable for the development of the nuclear transplant embryo into a viable offspring. In a related method, a permeabilized cell is incubated with a reprogramming media (e.g., a cell extract) to allow the addition or removal of factors from the cell, and then the plasma membrane of the permeabilized cell is resealed to enclose the desired factors and restore the membrane integrity of the cell. If desired, the steps of any of these methods may be repeated one or more times or different reprogramming methods may be performed sequentially to increase the extent of reprogramming, resulting in greater viability of the cloned fetuses. The invention also provides methods for generating chimeric embryos in which some or all of the placental tissue is from one genetic source and the majority of the fetal tissue is from another genetic source. These chimeric embryos may have fewer placental abnormalities and thus may have an increased survival rate. In addition, a novel method has been developed for the insertion of the chromatin mass or a nucleus into the recipient ooctye that involves the use of fusigenic compounds.

Problems solved by technology

Unfortunately, the efficiency of cloning mammals using donor somatic cells is generally low, resulting in only about 1-2% of nuclear transplant embryos developing to term (Polejaeva et al., Nature 407:86-90, 2000).

A significant problem with cloning is the loss of mid to late term pregnancies and the low viability of the offspring.

Images